Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Indianapolis, IN
SEC filing record 1 source field available
Fiscal year end
31 December
POINT Biopharma Global Inc. has filed 285 SEC EDGAR filings since 14 May 2020

SEC filing history

Showing 276-285 of 285 matching filings.

Per page
25
Current page
12
CORRESP

CORRESP filing

Filing date
06 Jul 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
06 Jul 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-239196

S-1/A

Filing date
06 Jul 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-239196

S-1/A

Filing date
29 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
26 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
25 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
16 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-239196

S-1

Filing date
15 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
10 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DRS File 377-03172

DRS filing

Filing date
14 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .